Candice Lesage

80 Avenue A Fliche, Montpellier 3409
Montpellier, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Roux-en-Y gastric bypass: impact of surgical approach on short-term postoperative complications.

Roux-en-Y gastric bypass: impact of surgical approach on short-term postoperative complications.

Journal: Journal of robotic surgery

Published: November 20, 2025

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.

Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 12, 2025

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Journal: The British journal of dermatology

Published: December 10, 2024

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.

Journal: Alimentary pharmacology & therapeutics

Published: June 18, 2024

Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.

Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.

Journal: Melanoma research

Published: March 28, 2024

Methotrexate in monotherapy or combined with oral steroids for bullous pemphigoid in a real-life setting: A retrospective monocentric cohort.

Methotrexate in monotherapy or combined with oral steroids for bullous pemphigoid in a real-life setting: A retrospective monocentric cohort.

Journal: Annales de dermatologie et de venereologie

Published: February 23, 2024

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Journal: Annales de dermatologie et de venereologie

Published: February 22, 2024

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).

Journal: The oncologist

Published: December 17, 2023

Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Journal: The oncologist

Published: September 20, 2023

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Journal: Cancers

Published: April 24, 2023

Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database

Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database

Journal: European journal of dermatology : EJD

Published: March 01, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026